ABMD Software
Overview
ABMD Software by HeartLung Corporation is an AI-powered, cloud-based tool that enables physicians to assess bone mineral density (BMD) from existing CT scans, facilitating early detection of osteoporosis without additional radiation exposure. It is a post-processing software that utilizes artificial intelligence to analyze chest and abdominal CT scans, providing automated bone mineral density reports. This approach allows healthcare providers to identify patients at risk for osteoporosis during routine imaging procedures, enhancing preventive care without the need for separate DEXA scans. ABMD Software is specifically designed for post-processing analysis of bone mineral density in individuals who have undergone a CT scan that includes vertebral bone. It is not intended to replace DXA or any other tests dedicated to BMD measurement, but rather to measure BMD in existing CT scans or CT scans ordered for reasons other than BMD measurement.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Real-time monitoring
- Predictive analytics
- Patient data management
- Clinical decision support
- Automated alerts
- Data visualization
- Integration with medical devices
- Customizable dashboards
- Reporting tools
- Clinical workflow optimization
- Data security features
- Regulatory compliance tracking
- User access controls
- Audit trails
- Data backup and recovery
- Mobile access
- Telemedicine support
- Interoperability with EHR systems
Use Cases
- Early detection of osteoporosis
- Opportunistic screening for bone mineral density from existing CT scans
- Identifying patients at risk for osteoporosis during routine imaging procedures
- Enhancing preventive care without dedicated DEXA scans
- Retrospective assessment of bone density from CT scans acquired for other purposes
- Assessment of bone density in conjunction with another medically appropriate procedure involving CT scans
What Physicians Need to Know
ABMD Software offers a valuable opportunity for opportunistic screening of osteoporosis using readily available CT scans, which can aid in early detection and preventive care. Physicians should integrate these AI-generated BMD reports with comprehensive clinical evaluations and consider them as complementary to, not a replacement for, dedicated DEXA scans. Collaboration with radiologists for interpretation of the AI-powered measurements is key for optimal patient management.
The cloud-based nature of ABMD Software and its compatibility with DICOM format for CT scans suggest straightforward integration into existing imaging workflows. Its stated interoperability with EHR systems further enhances its potential for seamless incorporation into clinical practice, allowing for automated data transfer and reporting.
Details
| Category | Endocrinology & Metabolic AI, Radiology & Imaging AI |
| Pricing | Contact for pricing |
| Deployment | Cloud-based |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated ABMD Software (K213760) received FDA 510(k) clearance on July 29, 2022. It is an AI-powered post-processing software intended to measure bone mineral density (BMD) from existing CT scans by averaging Hounsfield units in the trabecular region of vertebral bones. It is not intended to replace DXA or any other tests dedicated to BMD measurement, but rather to measure BMD in existing CT scans or CT scans ordered for reasons other than BMD measurement. |
| Integrations | |
| EHR | Not specified |
| Specialties | Endocrinology, Geriatrics, Radiology |
What the Web Says
HeartLung.AI (formerly ABMD Software) is a health-tech company that develops AI-enabled solutions for the early detection and prevention of various fatal conditions, including heart disease, lung cancer, osteoporosis, and fatty liver disease, using standard CT scans. Their flagship platform, AI-CVDu00ae, has received FDA clearance and Breakthrough Device Designation for several modules, allowing for automated extraction of clinically relevant measurements from existing CT scans without additional imaging or workflow disruption. The company has a strong focus on scientific research, with numerous studies accepted and presented at major medical conferences like the American Heart Association and the European Society of Cardiology, highlighting the effectiveness of their AI in improving early detection and patient outcomes.
Overall: PositiveStrengths
- AI-enabled early detection of multiple conditions (heart disease, lung cancer, osteoporosis, fatty liver disease) from existing CT scans.
- FDA clearance and Breakthrough Device Designation for key modules like AutoBMDu2122 and AutoChamberu2122.
- Transforms routine CT scans into comprehensive preventive health assessments.
- Reduces the need for additional imaging, radiation, or contrast.
- Strong scientific backing with numerous peer-reviewed studies and presentations at major medical conferences.
- Potential to improve population health, value-based care, and early disease prevention.
Limitations
- No specific cons were found in the provided search results regarding HeartLung.AI (ABMD Software).
- General concerns about FDA's AI review process for radiology algorithms have been raised in a JAMA Network Open article, noting that only a small percentage undergo prospective testing or testing with a human operator.
Based on reviews from: HeartLung's 2024 Year in Review - Milestones and Pipeline for 2025, HeartLung AI - AuntMinnie, FDA Clears HeartLung's AI-CVDu00ae, Enabling the Broadest Opportunistic Cardiovascular & Multisystem CT Screening Platform, Two HeartLung.AI Studies Show Routine Chest CT Assesses Cardiac R, FDA clears HeartLung's AI-CVD platform - AuntMinnie, Hear from Our Experts | Livelong - HeartLung.AI, HeartLung Technologies Sets New Milestone with Nine Accepted Abstracts at AHA 2025 Showcasing the Power of AI-CVD | FirstWord HealthTech, HeartLung Technologies to Present Four Scientific Research Studies on AI-CACu2122, AutoBMDu2122, and AI-CVDu2122 at the 2024 Radiological Society of North America (RSNA 2024), Imaging at AHA 2025, AI Replacement Rebuttal, and Mobile Lung CT Screening, HeartLung.AI Emerges as a Leading Innovator in Cardiology with 10 Accepted ESC.26 Abstracts
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate ABMD Software
Videos
Product demos, reviews, and walkthroughs for ABMD Software.
Switching Dealer Software Used to Feel Like a Heart Transplant
Full Throttle Podcast
How Does Heart Bypass Surgery Work? u21aa 3D Medical Animation #Shorts #SaphenousVein
ERemedium
3D Histech software bone marrow aspirate
Introducciu00f3n a la Hematologia clu00ednica
Cycling ud83dudeb2 during dialysis | Exercise on hemodialysis #neet #nephrology #doctor
Dialysis Study
Robotic Surgery Animation Video | Watch a Surgery Like Never Before
Dr Navin Agrawal CARDIO CARE
Right coronary artery with 80-90%, 90-99% and 100% blockage ( angiography) #shorts
Dr Nagendra Thalor MD medicine DM cardiology
